Weight Loss Drugs Won’t Eat Into Food Industry Profits, Nestlé CEO Says

Nestlé CEO Mark Schneider said appetite suppressing GLP-1 drugs like Ozempic, Wegovy and Mounjaro create an opportunity for the food industry amid customers’ “shifting” nutritional needs.

risingforbes

May 30, 2024 - 12:00

0 2

Weight Loss Drugs Won’t Eat Into Food Industry Profits, Nestlé CEO Says

Nestlé CEO Mark Schneider said appetite suppressing GLP-1 drugs like Ozempic, Wegovy and Mounjaro create an opportunity for the food industry amid customers’ “shifting” nutritional needs.

Weight Loss Drugs Won’t Eat Into Food Industry Profits, Nestlé CEO Says

Nestlé CEO Mark Schneider said appetite suppressing GLP-1 drugs like Ozempic, Wegovy and Mounjaro create an opportunity for the food industry amid customers’ “shifting” nutritional needs.

Tags:

What's Your Reaction?

Related Posts

Popular Posts